Neuropharmacological manipulations with MPTP

Area of Science:

• Neuroscience
• Toxicology
• Pharmacology

Background:

• MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin.
• MPTP selectively destroys dopaminergic neurons in the nigrostriatal pathway.
• MPTP's mechanism and selectivity are not fully understood.

Purpose of the Study:

• Assess MPTP's selectivity for the nigrostriatal system.
• Investigate melanin's influence on MPTP.
• Determine if MPTP metabolites contribute to dopamine cell toxicity.
• Identify MPTP's site(s) of action in the brain.
• Elucidate MPTP's mechanism of action and explore preventative strategies.

Main Methods:

• Peripheral administration of MPTP in rodents and marmosets.
• Assessment of dopamine and metabolite depletions.
• Use of MAO-B inhibitor (deprenyl).
• Intracerebral administration of MPP+ (1-methyl-4-phenylpyridinium).
• Behavioral and biochemical analyses.

Main Results:

• MPTP caused dopamine depletions in striatal and limbic systems in mice, irrespective of pigmentation.
• Deprenyl antagonized MPTP's effects.
• MPP+ disrupted striatal dopamine function when administered centrally.
• MPTP and MPP+ act in the midbrain, with potential forebrain actions under investigation.

Conclusions:

• MPTP's neurotoxic action, via MPP+, may not be limited to the nigrostriatal system.
• MPTP and MPP+ neurotoxicity are relevant to understanding Parkinson's disease etiology, treatment, and prevention.